FDA Doesn’t Need New “Hammers” For Drug Safety, Gottlieb Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Deputy commissioner says that improving technology, not revamping the agency’s oversight authority, will lead to post-marketing improvements.